SCHEMBL5899423

SCHEMBL5899423

O=C(CNS(=O)(=O)Cc1cccc(Cl)c1)c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.49
KMT2A Q03164 3/20 0.48
RXFP1 Q9HBX9 1/20 0.48
ERCC5 P28715 1/20 0.46
FEN1 P39748 1/20 0.46
KAT6A Q92794 1/20 0.44
TAS2R14 Q9NYV8 1/20 0.44
MEN1 O00255 2/20 0.44
ALDH1A1 P00352 1/20 0.44
HPGD P15428 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
RXRA P19793 1/20 0.44
RXRB P28702 1/20 0.44
RXRG P48443 1/20 0.44
GRIN2B Q13224 1/20 0.43
S100A9 P06702 1/20 0.43
KDM4E B2RXH2 1/20 0.43
NR4A2 P43354 1/20 0.43
MCL1 Q07820 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5899559 0.89 ACLY (0.51) AKR1C3KMT2AKAT6AMEN1ALDH1A1
SCHEMBL5320468 0.85 MMP1 (0.56) KMT2AERCC5FEN1MEN1ALDH1A1
SCHEMBL24590604 0.84 MAPT (0.57) KMT2AERCC5FEN1TAS2R14MEN1
SCHEMBL5899484 0.84 ALDH1A1 (0.50) AKR1C3KMT2AMEN1ALDH1A1HPGD
SCHEMBL5899475 0.79 ALDH1A1 (0.53) KMT2AMEN1ALDH1A1HPGDSMN1; SMN2
SCHEMBL16265375 0.76 MEN1 (0.52) KMT2AMEN1ALDH1A1HPGDSMN1; SMN2
SCHEMBL30511469 0.76 MAPT (0.66) KMT2AERCC5FEN1MEN1ALDH1A1
SCHEMBL16914842 0.76 CA1 (0.61) KMT2ARXFP1S100A9
SCHEMBL754846 0.76 ALDH1A1 (0.52) AKR1C3KMT2AERCC5FEN1KAT6A
SCHEMBL1515772 0.76 MAPT (0.66) KMT2AERCC5FEN1MEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060025445-A1 11-Beta HSD1 inhibitors WYETH 2006-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060025445-A1 11-Beta HSD1 inhibitors HSD11B1, HSD11B2, HSD3B1 AKR1C3 129/4885KMT2A 1509/4885RXFP1 1812/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.